Cargando…

Cell Fate Reprogramming in the Era of Cancer Immunotherapy

Advances in understanding how cancer cells interact with the immune system allowed the development of immunotherapeutic strategies, harnessing patients’ immune system to fight cancer. Dendritic cell-based vaccines are being explored to reactivate anti-tumor adaptive immunity. Immune checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermannova, Olga, Caiado, Inês, Ferreira, Alexandra G., Pereira, Carlos-Filipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336566/ https://www.ncbi.nlm.nih.gov/pubmed/34367185 http://dx.doi.org/10.3389/fimmu.2021.714822

Ejemplares similares

Reprogramming Cancer Cells to Antigen-presenting Cells
por: Ferreira, Alexandra G., et al.
Publicado: (2023)

T-helper cells flexibility: the possibility of reprogramming T cells fate
por: Khantakova, Julia N., et al.
Publicado: (2023)

Understanding and Modulating Immunity With Cell Reprogramming
por: Pires, Cristiana F., et al.
Publicado: (2019)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment
por: Li, Weiqiang, et al.
Publicado: (2023)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023)

Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
por: Wu, Xinyan, et al.
Publicado: (2023)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
por: Peyraud, Florent, et al.
Publicado: (2022)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

Epigenetic Reprogramming of CD4(+) Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
por: Renaude, Elodie, et al.
Publicado: (2021)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
por: Deng, Zhuoya, et al.
Publicado: (2022)

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
por: Kayser, Charlotte, et al.
Publicado: (2023)

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy
por: Asiry, Saeed, et al.
Publicado: (2021)

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
por: De Cicco, Paola, et al.
Publicado: (2020)

Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy
por: Velez, Antonio, et al.
Publicado: (2023)

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
por: Guram, Kripa, et al.
Publicado: (2019)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
por: Charo, Jehad, et al.
Publicado: (2023)

Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
por: Genard, Géraldine, et al.
Publicado: (2017)

Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
por: Khan, Safir Ullah, et al.
Publicado: (2023)

Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy
por: Podojil, Joseph R., et al.
Publicado: (2022)

Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer
por: Xu, Yan, et al.
Publicado: (2023)

Reprogramming cell fates by small molecules
por: Ma, Xiaojie, et al.
Publicado: (2017)

Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2022)

Lineage Reprogramming of Effector Regulatory T Cells in Cancer
por: Dixon, Michael L., et al.
Publicado: (2021)

Editorial: Immune Cell Lineage Reprogramming in Cancer
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Erratum: Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
Publicado: (2022)

Fate Mapping of Dendritic Cells
por: Poltorak, Mateusz Pawel, et al.
Publicado: (2015)

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
por: Wang, Yaqi, et al.
Publicado: (2022)

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Yang, Guanqun, et al.
Publicado: (2022)

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate
por: Ji, Yun, et al.
Publicado: (2019)

Cell Fate Reprogramming by Control of Intracellular Network Dynamics
por: Zañudo, Jorge G. T., et al.
Publicado: (2015)

Reprogramming cell fate: a changing story
por: Chin, Michael T.
Publicado: (2014)

Direct reprogramming and biomaterials for controlling cell fate
por: Kim, Eunsol, et al.
Publicado: (2016)

Epigenetic memory and cell fate reprogramming in plants
por: Birnbaum, Kenneth D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j0nfkcubdp9puf2ud648ons05v